Article
TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
PloS one - 1 Jan 2013
Peng Qiliu, Lao Xianjun, Chen Zhiping, Lai Hao, Deng Yan, Wang Jian, Mo Cuiju, Sui Jingzhe, Wu Junrong, Zhai Limin, Yang Shi, Qin Xue, Li Shan
Abstract excerpt
BACKGROUND: The association between TP53 R72P and/or MDM2 SNP309 polymorphisms and hepatocellular carcinoma (HCC) risk has been widely reported, but results were inconsistent. To clarify the effects of these polymorphisms on HCC risk, an updated meta-analysis of all available studies was conducted. METHODS: Eligible articles were identified by search of databases including PubMed, Cochrane Library, EMBASE and...
Topics
- Carcinoma, Hepatocellular
- Confidence Intervals
- Epistasis, Genetic
- Ethnicity
- Genetic Predisposition to Disease
- Humans
- Liver Neoplasms
- Odds Ratio
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins c-mdm2
